chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking so bad), MOVEMENT DISORDER (he couldn't sit up any longer), FEELING ABNORMAL (felt bad), THINKING ABNORMAL (wasn't thinking right) and NIGHT SWEATS (woke up soaking wet) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in November 2020. Concurrent medical conditions included Allergy, Blood cholesterol abnormal and Blood pressure abnormal. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced HEADACHE (slight headache). On 10-Feb-2021, the patient experienced TREMOR (shaking so bad), FEELING ABNORMAL (felt bad), FEELING OF RELAXATION (felt better), CHILLS (chills) and MYALGIA (arm was hurting). On 11-Feb-2021, the patient experienced MOVEMENT DISORDER (he couldn't sit up any longer), THINKING ABNORMAL (wasn't thinking right), NIGHT SWEATS (woke up soaking wet), DYSPNOEA (shortness of breath) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, TREMOR (shaking so bad), MOVEMENT DISORDER (he couldn't sit up any longer), FEELING ABNORMAL (felt bad), THINKING ABNORMAL (wasn't thinking right), NIGHT SWEATS (woke up soaking wet), DYSPNOEA (shortness of breath), FEELING OF RELAXATION (felt better), PYREXIA (fever), HEADACHE (slight headache), CHILLS (chills) and MYALGIA (arm was hurting) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Concomitant medication includes cholesterol med, blood pressure med, allergy medication. This case was linked to MOD-2021-255312. Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Significant follow-up - Lot no of suspect drug was updated.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Paraesthesia, Peripheral coldness, Vaccination site pruritus
Clinical narrative: tingling in hands and arms/tingling came back up the arm and up head; hand got cold; itchiness at the injection site; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (sore arm), VACCINATION SITE PRURITUS (itchiness at the injection site), PARAESTHESIA (tingling in hands and arms/tingling came back up the arm and up head) and PERIPHERAL COLDNESS (hand got cold) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced AXILLARY PAIN (sore arm).   On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at the injection site).   On 10-Feb-2021, the patient experienced PARAESTHESIA (tingling in hands and arms/tingling came back up the arm and up head) and PERIPHERAL COLDNESS (hand got cold).   The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency.   On 06-Feb-2021, VACCINATION SITE PRURITUS (itchiness at the injection site) had resolved. At the time of the report, AXILLARY PAIN (sore arm) and PERIPHERAL COLDNESS (hand got cold) outcome was unknown and PARAESTHESIA (tingling in hands and arms/tingling came back up the arm and up head) had not resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Tremendous back pain; Swollen Injection site; Red injection site; Painful injection site; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Tremendous back pain), INJECTION SITE SWELLING (Swollen Injection site), INJECTION SITE ERYTHEMA (Red injection site) and INJECTION SITE PAIN (Painful injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Tremendous back pain), INJECTION SITE SWELLING (Swollen Injection site), INJECTION SITE ERYTHEMA (Red injection site) and INJECTION SITE PAIN (Painful injection site). The patient was treated with IBUPROFEN at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 12-Feb-2021, BACK PAIN (Tremendous back pain), INJECTION SITE SWELLING (Swollen Injection site), INJECTION SITE ERYTHEMA (Red injection site) and INJECTION SITE PAIN (Painful injection site) had resolved.            No concomitant medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Significant follow up received and outcome of events updated to recovered.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia
Clinical narrative: fever of 101F; headache that would not stop and lasted all day; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 101F) and HEADACHE (headache that would not stop and lasted all day) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (fever of 101F) and HEADACHE (headache that would not stop and lasted all day). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Headache, at a dose of 2 dosage form. At the time of the report, PYREXIA (fever of 101F) and HEADACHE (headache that would not stop and lasted all day) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 101 f (High) 101 F.         No concomitant medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Administration site discolouration, Chills, Fatigue, Injection site pruritus, Vaccination site erythema
Clinical narrative: arm is now pink and not as red as before; itchy around the site of injection; red around the site of injection; fatigue; chills; arm rash, it was itchy around the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (arm rash, it was itchy around the site of injection), ADMINISTRATION SITE DISCOLOURATION (arm is now pink and not as red as before), INJECTION SITE PRURITUS (itchy around the site of injection), VACCINATION SITE ERYTHEMA (red around the site of injection) and FATIGUE (fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 07-Feb-2021, the patient experienced VACCINATION SITE RASH (arm rash, it was itchy around the site of injection), INJECTION SITE PRURITUS (itchy around the site of injection), VACCINATION SITE ERYTHEMA (red around the site of injection), FATIGUE (fatigue) and CHILLS (chills).   On 11-Feb-2021, the patient experienced ADMINISTRATION SITE DISCOLOURATION (arm is now pink and not as red as before). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and CORTISONE for Adverse event, at an unspecified dose and frequency. On 07-Feb-2021, CHILLS (chills) had resolved.   On 10-Feb-2021, FATIGUE (fatigue) had resolved.   At the time of the report, VACCINATION SITE RASH (arm rash, it was itchy around the site of injection), ADMINISTRATION SITE DISCOLOURATION (arm is now pink and not as red as before), INJECTION SITE PRURITUS (itchy around the site of injection) and VACCINATION SITE ERYTHEMA (red around the site of injection) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Patient's treatment details included Cold compresses. Concomitant product use was not provided by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: arm is now pink and not as red as before; itchy around the site of injection; red around the site of injection; fatigue; chills; arm rash, it was itchy around the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (arm rash, it was itchy around the site of injection), ADMINISTRATION SITE DISCOLOURATION (arm is now pink and not as red as before), INJECTION SITE PRURITUS (itchy around the site of injection), VACCINATION SITE ERYTHEMA (red around the site of injection) and FATIGUE (fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 07-Feb-2021, the patient experienced VACCINATION SITE RASH (arm rash, it was itchy around the site of injection), INJECTION SITE PRURITUS (itchy around the site of injection), VACCINATION SITE ERYTHEMA (red around the site of injection), FATIGUE (fatigue) and CHILLS (chills).   On 11-Feb-2021, the patient experienced ADMINISTRATION SITE DISCOLOURATION (arm is now pink and not as red as before). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and CORTISONE for Adverse event, at an unspecified dose and frequency. On 07-Feb-2021, CHILLS (chills) had resolved.   On 10-Feb-2021, FATIGUE (fatigue) had resolved.   At the time of the report, VACCINATION SITE RASH (arm rash, it was itchy around the site of injection), ADMINISTRATION SITE DISCOLOURATION (arm is now pink and not as red as before), INJECTION SITE PRURITUS (itchy around the site of injection) and VACCINATION SITE ERYTHEMA (red around the site of injection) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Patient's treatment details included Cold compresses. Concomitant product use was not provided by the reporter.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm was sore; A spontaneous report was received from a consumer concerning a 84-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm was sore.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 10 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 030M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) Arm was sore.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), arm was sore was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Body temperature increased, Dizziness, Headache, Malaise
Clinical narrative: Increase temperature; Dizziness; severe headache; felt sicker from the vaccine than when she had the virus; Sore throat; Body ache; very intense reaction; This spontaneous case was reported by a consumer and describes the occurrence of   in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for an unknown indication.     The patient's past medical history included No adverse event (No relevant medical history).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Vaccination site reaction
Clinical narrative: Increase temperature; Dizziness; severe headache; felt sicker from the vaccine than when she had the virus; Sore throat; Body ache; very intense reaction; This spontaneous case was reported by a consumer and describes the occurrence of   in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for an unknown indication.     The patient's past medical history included No adverse event (No relevant medical history).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Mood altered, Nausea, Vaccination site induration
Clinical narrative: Shoulder soreness; Felt yucky; Nausea; Rash at injection site the size of an orange; Hard at the injection site; Itchy at the injection site; Feeling kind of bad; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Shoulder soreness), FEELING ABNORMAL (Felt yucky), NAUSEA (Nausea), VACCINATION SITE RASH (Rash at injection site the size of an orange) and VACCINATION SITE INDURATION (Hard at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced NAUSEA (Nausea), VACCINATION SITE RASH (Rash at injection site the size of an orange), VACCINATION SITE INDURATION (Hard at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and MOOD ALTERED (Feeling kind of bad). On an unknown date, the patient experienced ARTHRALGIA (Shoulder soreness) and FEELING ABNORMAL (Felt yucky). The patient was treated with CORTISONE at a dose of cortisone10 cream. At the time of the report, ARTHRALGIA (Shoulder soreness) and FEELING ABNORMAL (Felt yucky) had resolved and NAUSEA (Nausea), VACCINATION SITE RASH (Rash at injection site the size of an orange), VACCINATION SITE INDURATION (Hard at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and MOOD ALTERED (Feeling kind of bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included cortisone10 cream. Concomitant medication details were not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Shoulder soreness; Felt yucky; Nausea; Rash at injection site the size of an orange; Hard at the injection site; Itchy at the injection site; Feeling kind of bad; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Shoulder soreness), FEELING ABNORMAL (Felt yucky), NAUSEA (Nausea), VACCINATION SITE RASH (Rash at injection site the size of an orange) and VACCINATION SITE INDURATION (Hard at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced NAUSEA (Nausea), VACCINATION SITE RASH (Rash at injection site the size of an orange), VACCINATION SITE INDURATION (Hard at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and MOOD ALTERED (Feeling kind of bad). On an unknown date, the patient experienced ARTHRALGIA (Shoulder soreness) and FEELING ABNORMAL (Felt yucky). The patient was treated with CORTISONE at a dose of cortisone10 cream. At the time of the report, ARTHRALGIA (Shoulder soreness) and FEELING ABNORMAL (Felt yucky) had resolved and NAUSEA (Nausea), VACCINATION SITE RASH (Rash at injection site the size of an orange), VACCINATION SITE INDURATION (Hard at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and MOOD ALTERED (Feeling kind of bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included cortisone10 cream. Concomitant medication details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Endodontic procedure, Headache, Myalgia, Pain
Clinical narrative: root canal; excruciating headache; I'm in a lot of pain; muscle pain; excruciating joint pain all over; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (I'm in a lot of pain), ENDODONTIC PROCEDURE (root canal), MYALGIA (muscle pain), ARTHRALGIA (excruciating joint pain all over) and HEADACHE (excruciating headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced PAIN (I'm in a lot of pain), MYALGIA (muscle pain) and ARTHRALGIA (excruciating joint pain all over). On 11-Feb-2021, the patient experienced ENDODONTIC PROCEDURE (root canal) and HEADACHE (excruciating headache). At the time of the report, PAIN (I'm in a lot of pain), ENDODONTIC PROCEDURE (root canal), MYALGIA (muscle pain), ARTHRALGIA (excruciating joint pain all over) and HEADACHE (excruciating headache) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Myalgia
Clinical narrative: Funny taste in my mouth; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Funny taste in my mouth) and MYALGIA (Muscle aches) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced MYALGIA (Muscle aches). On 03-Feb-2021, the patient experienced DYSGEUSIA (Funny taste in my mouth). At the time of the report, DYSGEUSIA (Funny taste in my mouth) and MYALGIA (Muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Patient was scheduled for his second dose of the vaccine on 03-Mar-2021.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Limb discomfort, Pain in extremity, Pyrexia
Clinical narrative: the arm was so sore that couldn't lie down in the arm; crumpling in the legs; 99°F fever; terrible terrible head ache, is not as sore as last night, last night was terrible,; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (the arm was so sore that couldn't lie down in the arm), LIMB DISCOMFORT (crumpling in the legs), PYREXIA (99°F fever) and HEADACHE (terrible terrible head ache, is not as sore as last night, last night was terrible,) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011120A) for COVID-19 vaccination.     No medical history  reported.  Concomitant products included ATORVASTATIN, PROBIOTICS NOS and EZETIMIBE (ZETIA) for an unknown indication, VITAMINS NOS.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (the arm was so sore that couldn't lie down in the arm), LIMB DISCOMFORT (crumpling in the legs), PYREXIA (99°F fever) and HEADACHE (terrible terrible head ache, is not as sore as last night, last night was terrible,). At the time of the report, PAIN IN EXTREMITY (the arm was so sore that couldn't lie down in the arm) and LIMB DISCOMFORT (crumpling in the legs) outcome was unknown, PYREXIA (99°F fever) had resolved and HEADACHE (terrible terrible head ache, is not as sore as last night, last night was terrible,) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99 f (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information include Tylenol. Concomitant medications also include protatin and lipisture. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Headache, Pain in extremity
Clinical narrative: She wasn't able to stand; headache; her extremities couldn't work at all.; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (She wasn't able to stand), PAIN IN EXTREMITY (her extremities couldn't work at all.) and HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided ).   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (her extremities couldn't work at all.). On 04-Feb-2021, the patient experienced DYSSTASIA (She wasn't able to stand) and HEADACHE (headache). On 11-Feb-2021, HEADACHE (headache) had resolved. At the time of the report, DYSSTASIA (She wasn't able to stand) and PAIN IN EXTREMITY (her extremities couldn't work at all.) outcome was unknown.            No concomitant medication reported   No treatment medication reported
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in elbow) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (pain in elbow). At the time of the report, ARTHRALGIA (pain in elbow) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment was not provided. Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: NNI case  No Follow up required.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: patient lost the sense of taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (patient lost the sense of taste) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 14-Feb-2021, the patient experienced AGEUSIA (patient lost the sense of taste). At the time of the report, AGEUSIA (patient lost the sense of taste) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Area feels slightly warm to the touch; 4-inch diameter that is slightly pink around the area; Itch around injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Area feels slightly warm to the touch), VACCINATION SITE PRURITUS (Itch around injection site), AXILLARY PAIN (Sore arm) and VACCINATION SITE ERYTHEMA (4-inch diameter that is slightly pink around the area) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced AXILLARY PAIN (Sore arm).   On 08-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itch around injection site).   On 09-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Area feels slightly warm to the touch) and VACCINATION SITE ERYTHEMA (4-inch diameter that is slightly pink around the area). The patient was treated with CORTISONE for Application site reaction NOS, at an unspecified dose and frequency.   On 01-Feb-2021, AXILLARY PAIN (Sore arm) had resolved. At the time of the report, VACCINATION SITE WARMTH (Area feels slightly warm to the touch) and VACCINATION SITE ERYTHEMA (4-inch diameter that is slightly pink around the area) outcome was unknown and VACCINATION SITE PRURITUS (Itch around injection site) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Pain, Pyrexia
Clinical narrative: FEVER; Shaking chiills; Body aches; doesnt feel well; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (FEVER), CHILLS (Shaking chiills), PAIN (Body aches) and FEELING ABNORMAL (doesnt feel well) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (FEVER), CHILLS (Shaking chiills), PAIN (Body aches) and FEELING ABNORMAL (doesnt feel well). At the time of the report, PYREXIA (FEVER), CHILLS (Shaking chiills), PAIN (Body aches) and FEELING ABNORMAL (doesnt feel well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: infection.  On an unknown date, the patient experienced the event(s) hypertension headache, headache in forehead.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), hypertension headache, headache in forehead was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Peripheral swelling, Pyrexia
Clinical narrative: her arm swelled up; had 102 temperature; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (her arm swelled up) and PYREXIA (had 102 temperature) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced PERIPHERAL SWELLING (her arm swelled up) and PYREXIA (had 102 temperature).   At the time of the report, PERIPHERAL SWELLING (her arm swelled up) and PYREXIA (had 102 temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) Patient had 102 body temperature..   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-032814 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Jan-2021, the patient experienced PAIN (Soreness). On 13-Jan-2021, PAIN (Soreness) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment medications of the patient were provided. No concomitant medications were provided.  Patient stated that on 8FEB2021 she was riding her bike when she was hit by a car she experienced whip lash and bruising from the accident
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Big case of shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Big case of shingles) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0255202A) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis since 07-Nov-2014 and High cholesterol since 01-Feb-2014. Concomitant products included ATORVASTATIN from 18-Dec-2019 to an unknown date for Cholesterol, VITAMIN D [VITAMIN D NOS] from 20-Jun-2011 to an unknown date for Osteoporosis, ALENDRONATE SODIUM (ALENDRONATE) from 07-Nov-2014 to an unknown date, CALCIUM, MAGNESIUM, ZINC (CALCIUM + MAGNESIUM + ZINK) from 20-Jun-2011 to an unknown date and VITAMIN B COMPLEX from 20-Jun-2011 to an unknown date for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced HERPES ZOSTER (Big case of shingles). At the time of the report, HERPES ZOSTER (Big case of shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided by the reporter.   This case was linked to MOD-2021-017057 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow-up information received on 23 APR 2021 Contain : Additional information received included reporter details. On 27-Apr-2021: Follow-up information received on 27 APR 2021 contains No New Information. On 29-Jun-2021: Significant follow-up information received
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Illness, Palpitations
Clinical narrative: Fast heart beat, palpitaions; Felt sick; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Fast heart beat, palpitaions) and ILLNESS (Felt sick) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PALPITATIONS (Fast heart beat, palpitaions) and ILLNESS (Felt sick). On 28-Jan-2021, PALPITATIONS (Fast heart beat, palpitaions) and ILLNESS (Felt sick) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: fast (High) fast heart beat.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medicines were reported. No treatment information were reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Pain in extremity
Clinical narrative: terrible headache; Arm soreness after a couple hours.; 2 finger numbness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness after a couple hours.), HYPOAESTHESIA (2 finger numbness) and HEADACHE (terrible headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concomitant products included METFORMIN for Diabetes, DILTIAZEM for Hypertension.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness after a couple hours.) and HYPOAESTHESIA (2 finger numbness). On an unknown date, the patient experienced HEADACHE (terrible headache). At the time of the report, PAIN IN EXTREMITY (Arm soreness after a couple hours.), HYPOAESTHESIA (2 finger numbness) and HEADACHE (terrible headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Pain, Pyrexia
Clinical narrative: Fever of 99.2; Arm aches at injection site; She aches all over her body, on back of right shoulder and neck; Mild headache; Chills; A spontaneous report was received from a consumer concerning a 66-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events Injection site pain, pain, headache, chills and pyrexia.     The patient's medical history was not provided. No relevant concomitant medications were reported.  On 13 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 011M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 13 Feb 2021, the patient experienced the events arm aches at injection site, she aches all over her body, On back of right shoulder and neck, mild headache, chills, fever of 99.2.  Treatment details included Aspirin.  Action taken with mRNA-1273 in response to the events was not reported.   At the time of this report, the outcome of events, arm aches at injection site, she aches all over her body,on back of right shoulder and neck,mild headache,chills,fever of 99,2 was unknown.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Injection site is warm; Injection site is red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site is warm) and VACCINATION SITE ERYTHEMA (Injection site is red) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Injection site is warm) and VACCINATION SITE ERYTHEMA (Injection site is red). At the time of the report, VACCINATION SITE WARMTH (Injection site is warm) and VACCINATION SITE ERYTHEMA (Injection site is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant was provided. Patient treatment information was not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lip swelling, Myalgia
Clinical narrative: Headaches; Chills; Body aches; Extreme fatigue; lips are swollen; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lips are swollen), HEADACHE (Headaches), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Extreme fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced LIP SWELLING (lips are swollen). On 10-Feb-2021, the patient experienced HEADACHE (Headaches), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Extreme fatigue). On 11-Feb-2021, HEADACHE (Headaches), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Extreme fatigue) had resolved. At the time of the report, LIP SWELLING (lips are swollen) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided. No treatment information provided.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Limb discomfort, Muscle fatigue, Muscle tightness
Clinical narrative: lower left leg vibration sensation; pain in the injection site; muscle fatigue; muscle tightness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (pain in the injection site), MUSCLE FATIGUE (muscle fatigue), MUSCLE TIGHTNESS (muscle tightness) and LIMB DISCOMFORT (lower left leg vibration sensation) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057620A) for COVID-19 vaccination.     The patient's past medical history included No adverse event, Diabetes and Asthma. Concomitant products included DULAGLUTIDE (TRULICITY), METFORMIN, DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE (XIGDUO XR), PIOGLITAZONE and GLIMEPIRIDE for Diabetes, MULTIVITAMINS [VITAMINS NOS] and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced INJECTION SITE PAIN (pain in the injection site), MUSCLE FATIGUE (muscle fatigue) and MUSCLE TIGHTNESS (muscle tightness). On 13-Feb-2021, the patient experienced LIMB DISCOMFORT (lower left leg vibration sensation). At the time of the report, INJECTION SITE PAIN (pain in the injection site), MUSCLE FATIGUE (muscle fatigue), MUSCLE TIGHTNESS (muscle tightness) and LIMB DISCOMFORT (lower left leg vibration sensation) outcome was unknown.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Illness, Pain, Pyrexia
Clinical narrative: Shortness of breath; Got very sick; Body aches; Headaches; 101 fever; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), ILLNESS (Got very sick), PAIN (Body aches), HEADACHE (Headaches) and PYREXIA (101 fever) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath), ILLNESS (Got very sick), PAIN (Body aches), HEADACHE (Headaches) and PYREXIA (101 fever). At the time of the report, DYSPNOEA (Shortness of breath), ILLNESS (Got very sick), PAIN (Body aches), HEADACHE (Headaches) and PYREXIA (101 fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided by Reporter.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Migraine, Nausea
Clinical narrative: feels exhausted; headache; migraine; diarrhea, a couple rounds of it; vomiting; nausea; A spontaneous report was received from a consumer concerning a 65-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events nausea, vomitting, migraine, headache, diarrhea, a couple rounds of it.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 10 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 015M20A) via unknown route for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced the event(s) nausea, vomitting, migraine, headache, diarrhea, a couple rounds of it.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), nausea, vomitting, migraine, headache, diarrhea, a couple rounds of it was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: feels exhausted; headache; migraine; diarrhea, a couple rounds of it; vomiting; nausea; A spontaneous report was received from a consumer concerning a 65-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events nausea, vomitting, migraine, headache, diarrhea, a couple rounds of it.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 10 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 015M20A) via unknown route for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced the event(s) nausea, vomitting, migraine, headache, diarrhea, a couple rounds of it.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), nausea, vomitting, migraine, headache, diarrhea, a couple rounds of it was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Cough, Depressed mood
Clinical narrative: Runny nose; Cough; Body aches; Pain in the body; Couldn't focus; Draining felling; Chills; Fatigue; Can´t smell; Can´t taste; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose), COUGH (Cough), MYALGIA (Body aches), PAIN (Pain in the body) and DISTURBANCE IN ATTENTION (Couldn't focus) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced ANOSMIA (Can´t smell) and AGEUSIA (Can´t taste). On an unknown date, the patient experienced RHINORRHOEA (Runny nose), COUGH (Cough), MYALGIA (Body aches), PAIN (Pain in the body), DISTURBANCE IN ATTENTION (Couldn't focus), DEPRESSED MOOD (Draining felling), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, RHINORRHOEA (Runny nose), COUGH (Cough), MYALGIA (Body aches), PAIN (Pain in the body), DISTURBANCE IN ATTENTION (Couldn't focus), DEPRESSED MOOD (Draining felling), ANOSMIA (Can´t smell), AGEUSIA (Can´t taste), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Disturbance in attention, Fatigue, Myalgia, Pain, Rhinorrhoea
Clinical narrative: Runny nose; Cough; Body aches; Pain in the body; Couldn't focus; Draining felling; Chills; Fatigue; Can´t smell; Can´t taste; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose), COUGH (Cough), MYALGIA (Body aches), PAIN (Pain in the body) and DISTURBANCE IN ATTENTION (Couldn't focus) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced ANOSMIA (Can´t smell) and AGEUSIA (Can´t taste). On an unknown date, the patient experienced RHINORRHOEA (Runny nose), COUGH (Cough), MYALGIA (Body aches), PAIN (Pain in the body), DISTURBANCE IN ATTENTION (Couldn't focus), DEPRESSED MOOD (Draining felling), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, RHINORRHOEA (Runny nose), COUGH (Cough), MYALGIA (Body aches), PAIN (Pain in the body), DISTURBANCE IN ATTENTION (Couldn't focus), DEPRESSED MOOD (Draining felling), ANOSMIA (Can´t smell), AGEUSIA (Can´t taste), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.